Exousia Bio, Inc. (LMMY) Gross margin 2024–2025
Exousia Bio, Inc. (LMMY) gross margin by fiscal year — reported gross profit divided by reported revenue.
-93.4%FY2025 · since FY2024: 15.9% → -93.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -93.4% | -109.3 pp |
| FY2024 | 15.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMMY financial trends
LMMY RevenueLMMY Net incomeLMMY Net marginLMMY Gross profitLMMY Operating incomeLMMY Operating marginLMMY Operating cash flowLMMY Free cash flowLMMY Capital expendituresLMMY Return on equityLMMY Stock buybacksLMMY Dividends paidLMMY Total assetsLMMY Total liabilitiesLMMY Shareholders’ equityLMMY overview →